We are live on ! Find out more
GNPX icon

Genprex

3 hedge funds and large institutions have $1.2M invested in Genprex in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

60% less capital invested

Capital invested by funds: $2.99M → $1.2M (-$1.8M)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

GNPX Hedge Fund Activity: Q4 2018 in Review

3 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q4 2018, worth a combined $1.2M — down 60% from $2.99M a quarter earlier.

Fund positioning in GNPX was balanced in Q4 2018: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $132K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $860K sold.

  • 3 institutional investors held Genprex (GNPX) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $1.2M of Genprex stock for Q4 2018, down 60% quarter-over-quarter.
  • 1 fund opened new Genprex positions in Q4 2018 and 1 closed out, a net change of 0 holders.
  • The largest Genprex buyer in Q4 2018 was Sabby Management, an estimated $132K added.
  • The largest Genprex seller in Q4 2018 was Hudson Bay Capital Management, an estimated $860K sold.

Based on aggregated 13F filings for Q4 2018.